SomaGenics, Inc. services

SomaGenics’ wound healing program addresses the pressing unmet medical need for the effective treatment of chronic wounds, most commonly, diabetic foot ulcers (DFUs).  Close to 25% of patients with diabetes develop foot ulcers with nearly 12% leading to amputation.  Current standard of care therapy is not effective and treatment usually requires costly extended hospital stays.  There is an immediate need for novel therapeutic strategies. 

Hepatitis delta virus (HDV) causes the most serious form of viral hepatitis and affects 15-20 million people worldwide.  HDV infection requires co-infection with Hepatitis B virus (HBV), and all HBV infected patients are at risk, although HDV co-infection often goes undetected. Hepatitis Delta Connect, a public outreach program, was recently established to increase both patient and physician awareness about the need to test for HDV among HBV patients since infection with this virus results in rapid liver damage.